PATENT CLAIM ANALYSIS

Application Number: 15564969
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-03
Patent Classification: ["424", "135100"]

Abstract:
The present invention provides, among other things, methods and compositions for treating chronic lung disorders, in particular, bronchopulmonary dysplasia (BPD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to BPD an effective amount of an anti-Flt-1 antibody, or antigen binding fragment thereof, such that at least one symptom or feature of BPD is reduced in intensity, severity, or frequency, or has delayed onset.

Claim (Index 22):
The method of  claim 21 , wherein the Fc region contains one or more mutations at one or more positions corresponding to Thr 250, Met 252, Ser 254, Thr 256, Thr 307, Glu 380, Met 428, His 433, and/or Asn 434 of human IgG1.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 88.0
- Lexical Diversity: 1.38462
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14763881', '12069757', '14605649', '11277121', '12220245']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6957998372419653
- 35 USC 102 Novelty (BERT): 0.5447164884805832
- Combined Prediction Score: 0.6806915023658271
- Mean Citation Score: 284.565086
- Max Citation Score: 380.26782
- Similarity Product: 235.54229414317845

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test